BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 21, 2007
View Archived Issues
Genzyme reports on active first quarter
Read More
Novel therapeutic agents for neurological disorders reported in recent patent literature
Read More
Novel compounds claimed for use in respiratory disease treatment
Read More
CNS-5161, an NMDA receptor antagonist, profiled in vitro and in vivo
Read More
Lovastatin to enter the clinic for the treatment of recurrent melanoma / News in Context
Read More
Y's Therapeutics advances YSPSL to phase II trials for I/R injury
Read More
FDA committee endorses FluMist for children under 5
Read More
Vernalis and Servier Research join forces for drug discovery
Read More
Oxygent enters phase II for patients undergoing CABG surgery
Read More
Genzyme reports encouraging results in Gaucher disease study
Read More
Patient enrollment begins in phase III AWARE trial with Generx
Read More
Obecure evaluates OBE-101's ability to reduce caloric intake in phase II
Read More
BMS's once-daily HIV medicine option approved in Canada
Read More
FDA provides feedback for design of Cell Therapeutics' pixantrone phase III trial
Read More
MLN-0002 clinical program back on track
Read More
Orphan drug designation assigned to Levulan in U.S.
Read More
MethylGene selects candidate from antifungal program for clinic
Read More
Celladon and Targeted Genetics advance Mydicar into the clinic
Read More
Patient enrollment complete for Tovaxin MS trial
Read More
MitoPharm's Schisandrin B may hold potential for antiaging concerns
Read More
ProtoKinetix's AAGP shows promise in preclinical studies for diabetes
Read More
Biolitec's Foscan combined with PDT in SpectraCure prostate cancer clinical trial
Read More
Peregrine to study bavituximab for HCV/HIV co-infection
Read More
DelSite obtains license to NIH technology for typhoid vaccine
Read More
Diractin filed for European approval
Read More
Seroquel XR receives FDA approval
Read More
Lovenox approved for patients with STEMI
Read More
Novel VEGF inhibitor shows therapeutic potential in psoriasis mouse model
Read More
Approvable letter for Mircera
Read More
Ceftobiprole filed for U.S. approval for cSSSI
Read More
SPD-465 receives approvable letter for ADHD
Read More